The leading global mid-size clinical Contract Research Organization
For comprehensive, clinical development services, TFS offers the highest level of competence, experience and personal attention to ensure we achieve the best results for our customers. With our suite of offerings, our customers' clinical trials will be handled with care and expertise.
TFS is in the business of improving and refining the delivery of better healthcare outcomes to ensure our customers' successes. We genuinely believe that being GLOBAL IN MIND AND LOCAL AT HEART is the core of our success; our customers know TFS' in-depth knowledge about regulatory and clinical trial requirements in every country, ensures a global trial will move faster to market and result in shorter timelines to get treatments to the patients who need them.
September 8th, 2020
May 27th, 2020
May 19th, 2020
Tuesday December 1stt at 9 am ET; 3 pm CET
Duration 1 hr.
Ocular gene therapy research has made rapid progress in the past few years. Find out about the rational for gene therapy in the eye and the progress so far in ocular gene therapy. The recent successful gene therapy clinical trials have been promising, but what are the next steps needed to develop ocular gene therapy further?
Listen to Prof. Prof. Andrew Lotery, from University Hospital Southampton, talking about Gene Therapy Approaches to Ophthalmic Treatment Needs.
Click here to register.